Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2023 March Clinical trials Long-term efficacy of tisagenlecleucel for paediatric and young patients with R/R B-ALL Read more
2023 March Clinical trials Tucidinostat, a promising therapeutic option for R/R peripheral T-cell lymphoma Read more
2023 March Clinical trials Ide-cel outperforms standard regimens in triple-class-exposed R/R multiple myeloma Read more
2023 March Clinical trials Dabrafenib plus trametinib induces durable responses in BRAF-mutated hairy cell leukaemia Read more
2023 March Medical Research Improved risk prediction model for multiple myeloma progression from precursor conditions Read more
2023 March Clinical trials Adding daratumumab to bortezomib-dexamethasone improves survival in myeloma patients Read more
Top
